Temporal arteritis: A cough, toothache, and tongue infarction

JAMA

Volumn 287, Issue 22, 2002, Pages 2996-3000

  Hellmann, David B ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; CASE REPORT; CLAUDICATION; CLINICAL FEATURE; COUGHING; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HEADACHE; HUMAN; INFARCTION; JAW DISEASE; ONSET AGE; PRIORITY JOURNAL; PYREXIA IDIOPATHICA; RESPIRATORY TRACT DISEASE; REVIEW; RHEUMATIC POLYMYALGIA; TEMPORAL ARTERITIS; TONGUE DISEASE; TOOTH PAIN; VISUAL IMPAIRMENT;

EID: 0037067152     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.287.22.2996     Document Type: Review

References (42)

1. Epidemiology of biopsy proven giant cell arteritis in northwestern Spain
2. Giant cell arteritis and polymyalgia rheumatica
3. Giant cell arteritis
4. Temporal arteritis
5. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985
6. Giant cell (cranial) arteritis: A clinical review
7. The HLA-DRB1 locus as a genetic component in giant cell arteritis
8. Arterial wall injury in giant cell arteritis
9. Temporal arteritis: A 25-year epidemiologic, clinical, and pathologic study
10. Inflamed shoulder structures in polymyalgia rheumatica with normal erythrocyte sedimentation rate
11. Visual manifestations of temporal arteritis
12. Musculoskeletal manifestations in polymyalgia rheumatica and temporal arteritis
13. Giant cell arteritis with low erythrocyte sedimentation rate
14. Temporal arteritis without an elevated erythrocyte sedimentation rate
15. Presentation of occult giant cell arteritis
16. Occult manifestations of giant cell arteritis
17. Nonclassical organ involvement in temporal arteritis
18. Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin
19. Fever and dry cough in a patient with a prosthetic heart valve
20. Respiratory tract symptoms as a clue to giant cell arteritis
21. Cough: A comprehensive review
22. Larger artery involvement in giant cell (temporal) arteritis
23. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis
24. Lower limb giant cell arteritis and temporal arteritis
25. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica
26. Systemic vasculitis presenting as a tumorlike lesion
27. Neurologic complications of giant cell (temporal) arteritis
28. Neurologic disease in biopsy-proven giant cell (temporal) arteritis
29. Disease patterns and tissue cytokine profiles in giant cell arteritis
30. Does this patient have temporal arteritis?
31. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
32. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis
33. How does previous corticosteroid treatment affect the biopsy findings in giant cell (temporal) arteritis?
34. Low diagnostic yield with second biopsies in suspected giant cell arteritis
35. Concordance of bilateral temporal artery biopsy in giant cell arteritis
36. Efficacy of unilateral versus bilateral temporal artery biopsies for the diagnosis of giant cell arteritis
37. Disease pattern in cranial and large-vessel giant cell arteritis
38. Color duplex ultrasonography in the diagnosis of temporal arteritis
39. Doppler ultrasonography in the diagnosis of giant cell arteritis
40. Adverse outcomes of anti-inflammatory therapy among patients with polymyalgia rheumatica
41. Combined treatment of giant-cell arteritis with methotrexate and prednisone
42. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA)